Gender disparities in utilization of statins for low density lipoprotein management across the spectrum of atherosclerotic cardiovascular disease: Insights from the houston methodist cardiovascular disease learning health system registry
{"title":"Gender disparities in utilization of statins for low density lipoprotein management across the spectrum of atherosclerotic cardiovascular disease: Insights from the houston methodist cardiovascular disease learning health system registry","authors":"","doi":"10.1016/j.ajpc.2024.100722","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Lower statin utilization is reported among women compared to men, however large-scale studies evaluating gender disparities in LDL-C management in individuals with ASCVD and its subtypes remain limited, particularly across age and racial/ethnic subgroups. In this study, we address this knowledge gap using data from a large US healthcare system.</p></div><div><h3>Methods</h3><p>All adult patients with established ASCVD in the Houston Methodist Learning Health System Registry during 2016–2022 were included. Statin use and dose were extracted from the database. The association between gender and statin utilization was evaluated using multivariate logistic regression analyses in patients with ASCVD overall, across ASCVD subtypes, and by age, racial/ethnic subgroups, and socioeconomic risk factors.</p></div><div><h3>Results</h3><p>A total of 97,819 patients with prevalent ASCVD were included. Women with ASCVD had lower utilization of any statin (64.3% vs 72.6 %; <em>p</em> < 0.001) and high-intensity statin (29.8% vs 42.5 % <em>p</em> < 0.001) compared with men. In fully adjusted models, women had 40 % lower odds of any (adjusted odds ratio [aOR]:0.58, 95 % CI 0.57–0.60) and high-intensity statin use (aOR:0.59, 0.57–0.61) relative to men. Women were also less likely to have guideline-recommended LDL-C < 70 mg/dL (30.2% vs 42.7 %; <em>p</em> < 0.01). These differences persisted across age, racial/ethnic and socioeconomic subgroups.</p></div><div><h3>Conclusion</h3><p>Significant gender disparities exist in contemporary lipid management among patients with ASCVD, with women being less likely to receive any and high-intensity statin and achieving guideline defined LDL-C goal compared with men across age and racial/ethnic subgroups. These disparities underscore the need to further understand potential socioeconomic drivers of the observed lower statin uptake in women.</p></div>","PeriodicalId":72173,"journal":{"name":"American journal of preventive cardiology","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666667724000904/pdfft?md5=674aa6502f57471edab59be01f1075ce&pid=1-s2.0-S2666667724000904-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of preventive cardiology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666667724000904","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Lower statin utilization is reported among women compared to men, however large-scale studies evaluating gender disparities in LDL-C management in individuals with ASCVD and its subtypes remain limited, particularly across age and racial/ethnic subgroups. In this study, we address this knowledge gap using data from a large US healthcare system.
Methods
All adult patients with established ASCVD in the Houston Methodist Learning Health System Registry during 2016–2022 were included. Statin use and dose were extracted from the database. The association between gender and statin utilization was evaluated using multivariate logistic regression analyses in patients with ASCVD overall, across ASCVD subtypes, and by age, racial/ethnic subgroups, and socioeconomic risk factors.
Results
A total of 97,819 patients with prevalent ASCVD were included. Women with ASCVD had lower utilization of any statin (64.3% vs 72.6 %; p < 0.001) and high-intensity statin (29.8% vs 42.5 % p < 0.001) compared with men. In fully adjusted models, women had 40 % lower odds of any (adjusted odds ratio [aOR]:0.58, 95 % CI 0.57–0.60) and high-intensity statin use (aOR:0.59, 0.57–0.61) relative to men. Women were also less likely to have guideline-recommended LDL-C < 70 mg/dL (30.2% vs 42.7 %; p < 0.01). These differences persisted across age, racial/ethnic and socioeconomic subgroups.
Conclusion
Significant gender disparities exist in contemporary lipid management among patients with ASCVD, with women being less likely to receive any and high-intensity statin and achieving guideline defined LDL-C goal compared with men across age and racial/ethnic subgroups. These disparities underscore the need to further understand potential socioeconomic drivers of the observed lower statin uptake in women.
导言:据报道,与男性相比,女性使用他汀类药物的比例较低,但是评估ASCVD及其亚型患者低密度脂蛋白胆固醇管理中性别差异的大规模研究仍然有限,尤其是在年龄和种族/民族亚群中。在本研究中,我们利用美国大型医疗保健系统的数据填补了这一知识空白。方法纳入休斯顿卫理公会学习健康系统登记处在 2016-2022 年期间所有已确诊 ASCVD 的成年患者。从数据库中提取他汀类药物的使用情况和剂量。使用多变量逻辑回归分析评估了ASCVD患者总体、不同ASCVD亚型以及年龄、种族/民族亚群和社会经济风险因素中性别与他汀类药物使用之间的关系。与男性相比,患有 ASCVD 的女性使用任何他汀类药物的比例较低(64.3% vs 72.6 %; p < 0.001),使用高强度他汀类药物的比例也较低(29.8% vs 42.5 % p < 0.001)。在完全调整模型中,女性使用任何他汀类药物(调整几率比 [aOR]:0.58,95 % CI 0.57-0.60)和高强度他汀类药物(aOR:0.59,0.57-0.61)的几率比男性低 40%。女性的低密度脂蛋白胆固醇达到指南推荐的 70 毫克/分升的可能性也较低(30.2% vs 42.7%;p < 0.01)。这些差异在不同年龄、种族/民族和社会经济亚群中持续存在。结论当代ASCVD患者的血脂管理存在显著的性别差异,在不同年龄和种族/民族亚群中,与男性相比,女性接受任何他汀类药物和高强度他汀类药物治疗以及达到指南规定的LDL-C目标的可能性较低。这些差异突出表明,有必要进一步了解导致女性他汀类药物摄入量较低的潜在社会经济因素。